EUVIMEDEUVIMED entdecken
Crossref

Stachydrine Protects Against Cyclophosphamide‐Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/ HO ‐1 Signalling Pathway

Cong Feng, Yue Jiang, Yuehui Zhang, Yu Liu, Lihong Zhang iD

Clinical and Experimental Pharmacology and Physiology · 2025-08 · 52 (8)

DOI: 10.1111/1440-1681.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 22.06.2025. Verfasst von Cong Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Cyclophosphamide, Primary Ovarian Insufficiency, Oxidative Stress, NF-E2-Related Factor 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Postdoctoral Special Funding of Heilongjiang Human Resources and Social Security Bureau, Joint Guidance Project of Heilongjiang Province, Postdoctoral General Project of Heilongjiang Human Resources and Social Security Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Excessive oxidative stress and apoptosis of ovarian granulosa cells lead to severe ovarian dysfunctions and even premature ovarian insufficiency (POI). Stachydrine (STA), the main active component of Leonurus japonicas , possesses antioxidant and anti‐apoptotic actions. However, the effects of STA on POI remain unknown. This work aimed to investigate STA's role in cyclophosphamide (CP)‐induced POI. CP was intraperitoneally injected into rats for 14 days (200 mg/kg for day 1, 8 mg/kg for day 2–14) to establish a POI model, and STA (20 or 40 mg/kg/d) was orally given to rats for three weeks after CP treatment. We found that STA treatment (40 mg/kg) alleviated the estrous cycle disorder and the imbalance of serum sex hormone levels in CP‐treated rats. Further, STA administration (40 mg/kg) inhibited oxidative stress and apoptosis of ovarian granulosa cells. Subsequently, human granulosa‐like cells (KGN) were treated with CP (250 μM) for 48 h, followed by STA administration (1 μM) for 24 h to investigate the in vitro effects of STA. Consistently, STA treatment prevented KGN cells from CP‐induced cell damage. In detail, STA treatment activated the Nrf2/HO‐1 signalling pathway, thereby inhibiting the oxidative stress and cell apoptosis of CP‐injured KGN cells. In conclusion, STA exerted a protective role in CP‐induced POI by alleviating oxidative stress and apoptosis through activating the Nrf2/HO‐1 signalling pathway, providing a new insight into POI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamidePrimary Ovarian InsufficiencyOxidative StressNF-E2-Related Factor 2ApoptosisHeme Oxygenase-1AnimalsFemaleSignal TransductionRatsRats, WistarHumansGranulosa CellsHeme Oxygenase (Decyclizing)Proline

Stichwörter der Autor:innen

HO‐1Nrf2Stachydrineapoptosisoxidative stresspremature ovarian insufficiency

Substanzen

CyclophosphamideNF-E2-Related Factor 2stachydrineNfe2l2 protein, ratHmox1 protein, ratHeme Oxygenase-1Heme Oxygenase (Decyclizing)Proline

Autor:innen und Institutionen

  • Department of Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
  • Department of Plastic and Maxillofacial Surgery, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, China.
  • Jiamusi College, Heilongjiang University of Chinese Medicine, Jiamusi, Heilongjiang, China.

ORCID-Profile: Lihong Zhang

Förderung

  • Postdoctoral Special Funding of Heilongjiang Human Resources and Social Security Bureau
  • Joint Guidance Project of Heilongjiang Province
  • Postdoctoral General Project of Heilongjiang Human Resources and Social Security Bureau
  • Youth Innovation Ability Training Plan of Heilongjiang University of Chinese Medicine

Zitieren

APA

Feng, C., Jiang, Y., Zhang, Y., Liu, Y., & Zhang, L. (2025). Stachydrine Protects Against Cyclophosphamide‐Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/ HO ‐1 Signalling Pathway. Clinical and Experimental Pharmacology and Physiology, 52(8). https://doi.org/10.1111/1440-1681.70052

Vancouver

Feng C, Jiang Y, Zhang Y, Liu Y, Zhang L. Stachydrine Protects Against Cyclophosphamide‐Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/ HO ‐1 Signalling Pathway. Clinical and Experimental Pharmacology and Physiology. 2025;52(8). doi:10.1111/1440-1681.70052

BibTeX
@article{Feng2025,
  author = {Feng, Cong and Jiang, Yue and Zhang, Yuehui and Liu, Yu and Zhang, Lihong},
  title = {Stachydrine Protects Against Cyclophosphamide‐Induced Premature Ovarian Insufficiency in Wistar Rats by Inhibiting Oxidative Stress and Apoptosis via the Activation of the Nrf2/ HO ‐1 Signalling Pathway},
  journal = {Clinical and Experimental Pharmacology and Physiology},
  year = {2025},
  volume = {52},
  number = {8},
  doi = {10.1111/1440-1681.70052}
}
Kostenlos starten →